Effect of lactate/albumin ratio on mortality in patients aged ≥ 65 years with community-acquired pneumonia
The Journal of Infection in Developing Countries · 2026
DOI: 10.3855/jidc.21662 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Infection in Developing Countries, 2026. Verfasst von Yaşar İncekara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Disease, Karamanoğlu Mehmetbey University, Faculty of Medicine, Karaman, Turkey. Hauptthemen laut MEDLINE: Community-Acquired Pneumonia, Lactic Acid, Serum Albumin. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Community-acquired pneumonia (CAP) remains a major cause of morbidity and mortality in elderly patients. Early identification of high-risk individuals is crucial for improving outcomes. Biomarkers derived from routine laboratory tests, such as the lactate / albumin (L/A) ratio, may provide valuable prognostic information. Methodology: This retrospective, two-center observational study included patients aged ≥ 65 years who were hospitalized with CAP between January 2021 and December 2024. Demographic characteristics, comorbidities, clinical severity scores, and laboratory parameters obtained at hospital admission were analyzed. Laboratory-derived ratios, including L/A, C-reactive protein/albumin (CRP/A), procalcitonin/albumin (PCT/A), and lactate dehydrogenase/albumin (LDH/A), were calculated. Receiver operating characteristic (ROC) analysis and logistic regression were performed to assess predictors of in-hospital mortality.
Results
A total of 150 patients were included, of whom 24% died during hospitalization. Non-survivors had significantly higher comorbidity burden, quick sepsis-related organ failure assessment (qSOFA) scores, lactate levels, and biomarker-based ratios. The L/A ratio was significantly associated with mortality (p < 0.001) and demonstrated moderate diagnostic performance (area under ROC, AUC = 0.263), with relatively favorable sensitivity and negative predictive value. Among the evaluated clinical scores, qSOFA showed the most balanced discriminatory performance. Multivariate analysis identified baseline oxygen saturation, Glasgow coma scale, albumin, and lactate levels as independent predictors of mortality.
Conclusions
The L/A ratio is a readily available biomarker associated with mortality in elderly patients with CAP. Although not a standalone predictor, it may serve as a complementary prognostic tool alongside established clinical severity scores, particularly during early patient assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary Disease, Karamanoğlu Mehmetbey University, Faculty of Medicine, Karaman, Turkey.
- Department of Infectious Diseases and Clinical Microbiology, Gaziantep City Hospital, Infectious Diseases and Clinical Microbiology, Gaziantep, Turkey.
- Department of Infectious Diseases and Clinical Microbiology, Gaziantep Islam Science and Technology University, Faculty of Medicine, Gaziantep, Turkey.
- Department of Pulmonary Disease, Mehmet Akif Ersoy Training and Research Hospital, Chest, Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey.
Zitieren
APA
İncekara, Y., Aslan, S., Şahin, A., & Çetinkaya, A. (2026). Effect of lactate/albumin ratio on mortality in patients aged ≥ 65 years with community-acquired pneumonia. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.21662
Vancouver
İncekara Y, Aslan S, Şahin A, Çetinkaya A. Effect of lactate/albumin ratio on mortality in patients aged ≥ 65 years with community-acquired pneumonia. The Journal of Infection in Developing Countries. 2026. doi:10.3855/jidc.21662
BibTeX
@article{ncekara2026,
author = {İncekara, Yaşar and Aslan, Selda and Şahin, Ahmet and Çetinkaya, Ali},
title = {Effect of lactate/albumin ratio on mortality in patients aged ≥ 65 years with community-acquired pneumonia},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
doi = {10.3855/jidc.21662}
}
EUVIMED